|
⚲
|
| Keyboard |
| Prior Stephen David
✚
|
|
|---|---|
| CIK # | 0002042268 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002042268] | |
| 4 | [0002042268] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AN2 Therapeutics Inc | |
| Prior Stephen David |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2026-01-06 | Sell | 2,858 | $1.01 | 2,887 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2026-01-05 | Sell | 3,604 | $1.00 | 3,604 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-11-04 | Sell | 765 | $1.14 | 872 |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2025-02-26 | Grant | 56,000 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-02-26 | Grant | 28,000 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-01-03 | Sell | 2,029 | $1.34 | 2,719 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-11-04 | Grant | 10,125 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2024-11-04 | Grant | 20,250 | $0.00 |